{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:22:29Z","timestamp":1785493349877,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600448"],"award-info":[{"award-number":["81600448"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974071"],"award-info":[{"award-number":["81974071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of autoimmune hepatitis (AIH) is increasing, and its early clinical diagnosis is difficult. The pathogenesis of AIH remains unclear, and AIH-related studies are largely limited because of lack of suitable mouse models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To obtain a good tool for research on AIH, we first established an improved immune-mediated mouse model that can mimic the pathological process of AIH as in the human body, through repeated injections of human cytochrome P450 2D6 (<jats:italic>CYP2D6<\/jats:italic>) plasmid. Next, a proteomic analysis based on isobaric tag (IBT) technology was performed to detect the differentially expressed proteins (DEPs), and related biological functions and pathways in the plasma of AIH and normal mice. Finally, we performed enzyme-linked immunosorbent assay (ELISA) to further confirm the most abundant DEP in the plasma of patients with AIH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Autoantibodies and the characteristic pathology of AIH were observed in our mouse model. Inflammatory infiltration also increased in the livers of AIH mice over time and plateaued by day 42 post the first injection. Chronic hepatitis was most severe on day 35 with the development of fibrosis as well, and the plasma of AIH mice were collected for proteomic analysis. A total of 176 DEPs were found in this experiment, of which 148 DEPs were up-regulated and 28 DEPs were down-regulated. Thirty significant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (P\u2009&lt;\u20090.05) were detected. Arginine biosynthesis was found to be the most significant pathway involved in the AIH process. During the Gene Ontology (GO) analysis, most DEPs were found to be involved in the binding, cellular, and metabolic processes. Using ELISA, the most overexpressed DEP, serum amyloid A 1 (SAA1), was confirmed to be increased specifically in the plasma of patients with AIH compared to other chronic hepatitis. Different plasma levels of SAA1 were also found related to different grades of inflammation and stages of fibrosis in the liver of patients with AIH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study is the first to describe the proteomics analysis of a true sense of AIH mouse model, which is beneficial for a better understanding of AIH pathogenesis and identifying potential biomarkers for its clinical diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-019-02180-3","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T10:02:28Z","timestamp":1578304948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Plasma proteomic analysis of autoimmune hepatitis in an improved AIH mouse model"],"prefix":"10.1186","volume":"18","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuohua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"2180_CR1","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","volume":"62","author":"AJ Czaja","year":"2017","unstructured":"Czaja AJ. Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis. Dig Dis Sci. 2017;62:2277\u201392.","journal-title":"Dig Dis Sci"},{"key":"2180_CR2","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","volume":"62","author":"MP Manns","year":"2015","unstructured":"Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis\u2014update 2015. J Hepatol. 2015;62:S100\u201311.","journal-title":"J Hepatol"},{"key":"2180_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/hep.20804","volume":"42","author":"MA Heneghan","year":"2005","unstructured":"Heneghan MA, McFarlane IG. Of mice and women: toward a mouse model of autoimmune hepatitis. Hepatology. 2005;42:17\u201320.","journal-title":"Hepatology"},{"key":"2180_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1159\/000489074","volume":"46","author":"T Ye","year":"2018","unstructured":"Ye T, Wang T, Yang X, Fan X, Wen M, Shen Y, Xi X, Men R, Yang L. Comparison of concanavalin A-induced murine autoimmune hepatitis models. Cell Physiol Biochem. 2018;46:1241\u201351.","journal-title":"Cell Physiol Biochem"},{"key":"2180_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/hep.26027","volume":"57","author":"J Kato","year":"2013","unstructured":"Kato J, Okamoto T, Motoyama H, Uchiyama R, Kirchhofer D, Van Rooijen N, Enomoto H, Nishiguchi S, Kawada N, Fujimoto J, Tsutsui H. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology. 2013;57:362\u201372.","journal-title":"Hepatology"},{"key":"2180_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","volume":"111","author":"S Kusters","year":"1996","unstructured":"Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 1996;111:462\u201371.","journal-title":"Gastroenterology"},{"key":"2180_CR7","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.4049\/jimmunol.0900547","volume":"183","author":"M Nakaya","year":"2009","unstructured":"Nakaya M, Hashimoto M, Nakagawa R, Wakabayashi Y, Ishizaki T, Takada I, Komai K, Yoshida H, Yoshimura A. SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis. J Immunol. 2009;183:7047\u201353.","journal-title":"J Immunol"},{"key":"2180_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI115836","volume":"90","author":"G Tiegs","year":"1992","unstructured":"Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90:196\u2013203.","journal-title":"J Clin Invest"},{"key":"2180_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","volume":"13","author":"GJ Webb","year":"2018","unstructured":"Webb GJ, Hirschfield GM, Krawitt EL, Gershwin ME. Cellular and molecular mechanisms of autoimmune hepatitis. Annu Rev Pathol. 2018;13:247\u201392.","journal-title":"Annu Rev Pathol"},{"key":"2180_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2016.12.001","volume":"78","author":"M Hardtke-Wolenski","year":"2017","unstructured":"Hardtke-Wolenski M, Dywicki J, Fischer K, Hapke M, Sievers M, Schlue J, Anderson MS, Taubert R, Noyan F, Manns MP, Jaeckel E. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development. J Autoimmun. 2017;78:39\u201345.","journal-title":"J Autoimmun"},{"key":"2180_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","volume":"75","author":"R Liberal","year":"2016","unstructured":"Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016;75:6\u201319.","journal-title":"J Autoimmun"},{"key":"2180_CR12","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/hep.27998","volume":"62","author":"M Yuksel","year":"2015","unstructured":"Yuksel M, Wang Y, Tai N, Peng J, Guo J, Beland K, Lapierre P, David C, Alvarez F, Colle I, et al. A novel \u201chumanized mouse\u201d model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology. 2015;62:1536\u201350.","journal-title":"Hepatology"},{"key":"2180_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","volume":"205","author":"M Holdener","year":"2008","unstructured":"Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, Johnson EF, Gonzalez FJ, Pfeilschifter J, Manns MP, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med. 2008;205:1409\u201322.","journal-title":"J Exp Med"},{"key":"2180_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/cei.12843","volume":"186","author":"M Yuksel","year":"2016","unstructured":"Yuksel M, Xiao X, Tai N, Vijay GM, Gulden E, Beland K, Lapierre P, Alvarez F, Hu Z, Colle I, et al. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model. Clin Exp Immunol. 2016;186:164\u201376.","journal-title":"Clin Exp Immunol"},{"key":"2180_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"2180_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","volume":"9","author":"M Sebode","year":"2018","unstructured":"Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance. Front Immunol. 2018;9:609.","journal-title":"Front Immunol"},{"key":"2180_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/cmi.2010.72","volume":"8","author":"CL Bowlus","year":"2011","unstructured":"Bowlus CL, Seeley EH, Roder J, Grigorieva J, Roder H, Caprioli RM, Gershwin M. In situ mass spectrometry of autoimmune liver diseases. Cell Mol Immunol. 2011;8:237\u201342.","journal-title":"Cell Mol Immunol"},{"key":"2180_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/hep.22149","volume":"47","author":"F Tahiri","year":"2008","unstructured":"Tahiri F, Le Naour F, Huguet S, Lai-Kuen R, Samuel D, Johanet C, Saubamea B, Tricottet V, Duclos-Vallee JC, Ballot E. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology. 2008;47:937\u201348.","journal-title":"Hepatology"},{"key":"2180_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbrc.2007.12.075","volume":"367","author":"F Lu","year":"2008","unstructured":"Lu F, Xia Q, Ma Y, Yuan G, Yan H, Qian L, Hu M, Wang M, Lu H, Wang H, et al. Serum proteomic-based analysis for the identification of a potential serological marker for autoimmune hepatitis. Biochem Biophys Res Commun. 2008;367:284\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"2180_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","volume":"24","author":"GH Sack Jr","year":"2018","unstructured":"Sack GH Jr. Serum amyloid A\u2014a review. Mol Med. 2018;24:46.","journal-title":"Mol Med"},{"key":"2180_CR21","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1074\/jbc.M114.635763","volume":"290","author":"YR Ji","year":"2015","unstructured":"Ji YR, Kim HJ, Bae KB, Lee S, Kim MO, Ryoo ZY. Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice. J Biol Chem. 2015;290:12804\u201311.","journal-title":"J Biol Chem"},{"key":"2180_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jconrel.2012.05.018","volume":"161","author":"S Yan","year":"2012","unstructured":"Yan S, Fu Q, Zhou Y, Wang J, Liu Y, Duan X, Jia S, Peng J, Gao B, Du J, et al. High levels of gene expression in the hepatocytes of adult mice, neonatal mice and tree shrews via retro-orbital sinus hydrodynamic injections of naked plasmid DNA. J Control Release. 2012;161:763\u201371.","journal-title":"J Control Release"},{"key":"2180_CR23","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1002\/pmic.201300361","volume":"14","author":"B Wen","year":"2014","unstructured":"Wen B, Zhou R, Feng Q, Wang Q, Wang J, Liu S. IQuant: an automated pipeline for quantitative proteomics based upon isobaric tags. Proteomics. 2014;14:2280\u20135.","journal-title":"Proteomics"},{"key":"2180_CR24","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1074\/mcp.M114.046995","volume":"14","author":"MM Savitski","year":"2015","unstructured":"Savitski MM, Wilhelm M, Hahne H, Kuster B, Bantscheff M. A scalable approach for protein false discovery rate estimation in large proteomic data sets. Mol Cell Proteom. 2015;14:2394\u2013404.","journal-title":"Mol Cell Proteom"},{"key":"2180_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1089-3261(02)00009-0","volume":"6","author":"PJ Scheuer","year":"2002","unstructured":"Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis. 2002;6:335\u201347.","journal-title":"Clin Liver Dis"},{"key":"2180_CR26","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gki005","volume":"33","author":"C von Mering","year":"2005","unstructured":"von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA, Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33:D433\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2180_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.10.022","volume":"95","author":"R Taubert","year":"2018","unstructured":"Taubert R, Hupa-Breier KL, Jaeckel E, Manns MP. Novel therapeutic targets in autoimmune hepatitis. J Autoimmun. 2018;95:34\u201346.","journal-title":"J Autoimmun"},{"key":"2180_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.amjmed.2004.01.026","volume":"117","author":"R Malekzadeh","year":"2004","unstructured":"Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, Rakhshani N, Tavangar SM, Sohrabpour AA, Tahaghoghi S. Reversibility of cirrhosis in autoimmune hepatitis. Am J Med. 2004;117:125\u20139.","journal-title":"Am J Med"},{"key":"2180_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1479-5876-11-146","volume":"11","author":"HLG Li","year":"2013","unstructured":"Li HLG, Zhao X, Wu Y, Ma W, Liu Y, Gong F, Liang S. Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients. J Transl Med. 2013;11:146.","journal-title":"J Transl Med"},{"key":"2180_CR30","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/hum.1994.5.12-1477","volume":"5","author":"MA Hickman","year":"1994","unstructured":"Hickman MA, Malone RW, Lehmann-Bruinsma K, Sih TR, Knoell D, Szoka FC, Walzem R, Carlson DM, Powell JS. Gene expression following direct injection of DNA into liver. Hum Gene Ther. 1994;5:1477\u201383.","journal-title":"Hum Gene Ther"},{"key":"2180_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cld.2015.08.003","volume":"20","author":"SIP Marzorati","year":"2016","unstructured":"Marzorati SIP, Lleo A. Making sense of autoantibodies in cholestatic liver diseases. Clin Liver Dis. 2016;20:33\u201346.","journal-title":"Clin Liver Dis"},{"key":"2180_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00281-012-0328-6","volume":"35","author":"D Vergani","year":"2013","unstructured":"Vergani D, Mieli-Vergani G. Autoimmune manifestations in viral hepatitis. Semin Immunopathol. 2013;35:73\u201385.","journal-title":"Semin Immunopathol"},{"key":"2180_CR33","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/pmic.200300757","volume":"4","author":"S Huguet","year":"2004","unstructured":"Huguet S, Labas V, Duclos-Vallee JC, Bruneel A, Vinh J, Samuel D, Johanet C, Ballot E. Heterogeneous nuclear ribonucleoprotein A2\/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis. Proteomics. 2004;4:1341\u20135.","journal-title":"Proteomics"},{"key":"2180_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mib.2015.10.005","volume":"29","author":"M Gogoi","year":"2016","unstructured":"Gogoi M, Datey A, Wilson KT, Chakravortty D. Dual role of arginine metabolism in establishing pathogenesis. Curr Opin Microbiol. 2016;29:43\u20138.","journal-title":"Curr Opin Microbiol"},{"key":"2180_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1668","volume":"5","author":"V Bronte","year":"2005","unstructured":"Bronte V, Zanovello P. Regulation of immune responses by l-arginine metabolism. Nat Rev Immunol. 2005;5:641\u201354.","journal-title":"Nat Rev Immunol"},{"key":"2180_CR36","doi-asserted-by":"publisher","first-page":"1681S","DOI":"10.1093\/jn\/137.6.1681S","volume":"137","author":"PJ Popovic","year":"2007","unstructured":"Popovic PJ, Zeh HJ III, Ochoa JB. Arginine and immunity. J Nutr. 2007;137:1681S\u20136S.","journal-title":"J Nutr"},{"key":"2180_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1568-9972(02)00128-3","volume":"2","author":"MAM van Boekel","year":"2003","unstructured":"van Boekel MAM, van Venrooij WJ. Modifications of arginines and their role in autoimmunity. Autoimmun Rev. 2003;2:57\u201362.","journal-title":"Autoimmun Rev"},{"key":"2180_CR38","doi-asserted-by":"publisher","first-page":"L328","DOI":"10.1152\/ajplung.00156.2016","volume":"311","author":"IE Kammerl","year":"2016","unstructured":"Kammerl IE, Meiners S. Proteasome function shapes innate and adaptive immune responses. Am J Physiol Lung Cell Mol Physiol. 2016;311:L328\u201336.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2180_CR39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.seminhematol.2012.04.004","volume":"49","author":"E Moran","year":"2012","unstructured":"Moran E, Carbone F, Augusti V, Patrone F, Ballestrero A, Nencioni A. Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. Semin Hematol. 2012;49:270\u20136.","journal-title":"Semin Hematol"},{"key":"2180_CR40","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1034\/j.1600-6143.2002.21006.x","volume":"2","author":"J Wu","year":"2002","unstructured":"Wu J. On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants. Am J Transplant. 2002;2:904\u201312.","journal-title":"Am J Transplant"},{"key":"2180_CR41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MOL.0000000000000331","volume":"27","author":"GS Getz","year":"2016","unstructured":"Getz GS, Krishack PA, Reardon CA. Serum amyloid A and atherosclerosis. Curr Opin Lipidol. 2016;27:531\u20135.","journal-title":"Curr Opin Lipidol"},{"key":"2180_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","volume":"583","author":"L Sun","year":"2016","unstructured":"Sun L, Ye RD. Serum amyloid A1: structure, function and gene polymorphism. Gene. 2016;583:48\u201357.","journal-title":"Gene"},{"key":"2180_CR43","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/onc.2013.568","volume":"34","author":"MT Hansen","year":"2015","unstructured":"Hansen MT, Forst B, Cremers N, Quagliata L, Ambartsumian N, Grum-Schwensen B, Klingelhofer J, Abdul-Al A, Herrmann P, Osterland M, et al. A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4. Oncogene. 2015;34:424\u201335.","journal-title":"Oncogene"},{"key":"2180_CR44","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1097\/MIB.0000000000001208","volume":"23","author":"MS Tang","year":"2017","unstructured":"Tang MS, Bowcutt R, Leung JM, Wolff MJ, Gundra UM, Hudesman D, Malter LB, Poles MA, Chen LA, Pei Z, et al. Integrated analysis of biopsies from inflammatory bowel disease patients identifies SAA1 as a link between mucosal microbes with TH17 and TH22 Cells. Inflamm Bowel Dis. 2017;23:1544\u201354.","journal-title":"Inflamm Bowel Dis"},{"key":"2180_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4149\/neo_2014_001","volume":"61","author":"X He","year":"2014","unstructured":"He X, Wang Y, Zhang W, Li H, Luo R, Zhou Y, Liao CLM, Huang H, Lv X, Xie Z, He M. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ\u2013MALDI-MS\/MS. Neoplasma. 2014;61:17\u201326.","journal-title":"Neoplasma"},{"key":"2180_CR46","first-page":"1271","volume":"24","author":"HK Shu","year":"2010","unstructured":"Shu HK, Kang X, Guo K, Li S, Li M, Sun L, Gan L, Liu Y, Qin X. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to \u03b1 fetoprotein. Oncol Rep. 2010;24:1271\u20136.","journal-title":"Oncol Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-02180-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:29:26Z","timestamp":1609806566000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-02180-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-02180-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"30 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of this study was approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology and all the participating patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}